Page last updated: 2024-10-21

ro 48-8071 and Malaria

ro 48-8071 has been researched along with Malaria in 1 studies

Ro 48-8071: a cholesterol synthesis inhibitor; structure in first source
Ro 48-8071 : An aromatic ketone that is 2-fluoro-4'-bromobenzophenone in which the hydrogen at position 4 (meta to the fluoro group) is replaced by a 6-[methyl(prop-2-en-1-yl)amino]hexyl}oxy group. An inhibitor of lanosterol synthase.

Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tonhosolo, R1
Gabriel, HB1
Matsumura, MY1
Cabral, FJ1
Yamamoto, MM1
D'Alexandri, FL1
Sussmann, RAC1
Belmonte, R1
Peres, VJ1
Crick, DC1
Wunderlich, G1
Kimura, EA1
Katzin, AM1

Other Studies

1 other study available for ro 48-8071 and Malaria

ArticleYear
Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone.
    FEBS letters, 2010, Dec-01, Volume: 584, Issue:23

    Topics: Anaerobiosis; Animals; Benzophenones; Electrons; Erythrocytes; Life Cycle Stages; Malaria; Molecular

2010